RAPAMYCIN BASED IMMUNOSUPPRESSION AMELIORATES CARDIAC ALLOGRAFT VASCULOPATHY

被引：0
|
作者：
GOGGINS, WC [1 ]
FISHER, RA [1 ]
COHEN, DS [1 ]
TAWES, JW [1 ]
GRIMES, MM [1 ]
机构：
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298
来源：
CIRCULATION | 1995年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1165 / 1165
页数：1
相关论文
共 50 条
  • [1] Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy
    Goggins, WC
    Fisher, RA
    Cohen, DS
    Tawes, JW
    Grimes, MM
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1996, 15 (08): : 790 - 795
  • [2] Immunomodulation of cardiac allograft vasculopathy: beyond immunosuppression
    Ortiz, Miguel A.
    Campana, Gonzalo
    Woods, John R.
    Labarrere, Carlos A.
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2008, 5 (04): : 369 - 373
  • [3] Immunosuppression and Cardiac Allograft Vasculopathy: A Multivariate Odds Ratio Analysis
    Hord, K.
    Dolan, R.
    Huang, Y.
    Knezevic, A.
    Gupta, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S200 - S201
  • [4] Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy
    El-Sayed, O
    Magorien, RD
    Orsini, A
    Ferketich, AK
    Leier, CV
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (02) : 137 - 141
  • [5] Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression
    Ruygrok, PN
    Webber, B
    Faddy, S
    Muller, DW
    Keogh, A
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (11): : 1276 - 1279
  • [6] Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy
    Bellumkonda, Lavanya
    Patel, Jignesh
    CLINICAL TRANSPLANTATION, 2020, 34 (01)
  • [7] THE PROGNOSTIC IMPACT OF IMMUNOSUPPRESSION AND CELLULAR REJECTION ON CARDIAC ALLOGRAFT VASCULOPATHY - TIME FOR A REAPPRAISAL
    MEHRA, MR
    VENTURA, HO
    CHAMBERS, R
    SMART, FW
    STAPLETON, DD
    CIRCULATION, 1995, 92 (08) : 1169 - 1169
  • [8] Sirolimus as primary immunosuppression is effective in attenuating progression of cardiac-allograft vasculopathy
    Joren C Madsen
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 : 300 - 301
  • [9] Cardiac allograft vasculopathy
    Behrendt, D
    Ganz, P
    Fang, JC
    CURRENT OPINION IN CARDIOLOGY, 2000, 15 (06) : 422 - 429
  • [10] Cardiac Allograft Vasculopathy
    Lee, Michael S.
    Finch, Will
    Weisz, Giora
    Kirtane, Ajay J.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (03) : 143 - 152
12345